DT
BLUE

Diversified Trust’s bluebird bio BLUE Stock Holding History

Diversified Trust’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-760
Closed -$46.2K – 885
2023
Q3 		$46.2K Hold
760
– – ﹤0.01% 805
2023
Q2 		$50K Sell
760
-18
-2% -$1.32K ﹤0.01% 811
2023
Q1 		$49.5K Buy
+778
New +$88.8K ﹤0.01% 800

Other funds holding BLUE

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
GCM
Ghisallo Capital Management Boston, Massachusetts $3.63B AUM 30.51% 1-Year Est. Return

Diversified Trust's BLUE Position: Q4 2023 in Review

Diversified Trust sold out of bluebird bio (BLUE) in Q4 2023, closing a stake of 760 shares — an estimated $46.2K sold.

Diversified Trust first reported a position in BLUE in Q1 2023 and held it in 3 quarters. The position peaked at $50K in Q2 2023. 187 funds tracked by Wall St. Rank hold BLUE as of Q4 2023.

  • Diversified Trust reported no remaining bluebird bio position as of Q4 2023 after selling out during the quarter.
  • Diversified Trust sold 760 bluebird bio shares in Q4 2023, an estimated $46.2K.
  • Diversified Trust first reported a position in bluebird bio in Q1 2023 and held it in 3 quarters.
  • Diversified Trust's bluebird bio position peaked at $50K in Q2 2023.
  • 187 funds tracked by Wall St. Rank held bluebird bio as of Q4 2023.

Based on Diversified Trust's 13F filing for Q4 2023, filed 8 Jan 2024.